Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

peritonitis/rasvumus

Link salvestatakse lõikelauale
Leht 1 alates 198 tulemused

Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
IL-17A is a proinflammatory cytokine critical for host defense and involved in the pathogenesis of autoimmune disorders. Obesity is associated with chronic low-grade inflammation but also with a heightened acute inflammatory response. We investigated the effect of obesity on IL-17A production using

LAP-banding obesity: a case of stomach perforation, peritonitis, and death.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We present a case of peritonitis and death due to the misplacement of a laparoscopic adjustable band inserted through, instead of around, the stomach. This represents the first case in the published literature where a LAP-BAND perforated the stomach, followed by peritonitis and death. The morbidly

The obesity paradox in surgical intensive care patients with peritonitis.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE Although obesity is usually regarded as a risk factor in surgical patients, various observations have revealed a better outcome in the obese. This finding is called the obesity paradox. To which group of patients the paradox applies and even whether it exists at all are matters of

Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Data on obesity as a risk factor for peritonitis and catheter infections among peritoneal dialysis (PD) patients are limited. Furthermore, little is known about the microbiology of PD-related infections among patients with a high body mass index (BMI). METHODS Using a cohort that included
OBJECTIVE The aim of the present investigation was to examine the association between body mass index (BMI) and peritonitis rates among incident peritoneal dialysis (PD) patients in a large cohort with long-term follow-up. METHODS Retrospective observational cohort study of the Australian and New
BACKGROUND The prevalence of severe obesity, often considered a contraindication to peritoneal dialysis (PD), has increased over time. However, mortality has decreased more rapidly in the PD population than the hemodialysis (HD) population in the United States. The association between obesity and

Chylous ascites mimicking peritonitis after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Biliary peritonitis after endoscopic sutured gastroplasty for morbid obesity (with video).

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

[Primary acute peritonitis in adults].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The authors report 12 cases of primary acute peritonitis-that were operated over a period of 10 years, representing 2.8% of the total number of acute cases of peritonitis, with the exclusion of cases of postoperative peritonitis. Since they are so rare it is understandable that primary acute
BACKGROUND Double-layer dermal grafts are used for the management of complicated abdominal wall hernias in obese, high risk patients. The method has not yet been used in case of emergency in septic/dirty environment. METHODS A 76-year old female patient (BMI 36.7kg/m2) was admitted with mechanical

Gastric stapling for morbid obesity: gastrointestinal response in a rat model.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The adaptive response of the gastrointestinal tract to gastric stapling was studied in a Zucker (fafa) genetically obese rat model. The effects of gastric stapling in rats with a Roux-en-Y gastrojejunostomy were compared to Roux-en-Y and intact controls. Rats (225 to 275 g) were divided into three
BACKGROUND Morbid obesity is effectively treated by restrictive surgery. A severe complication associated with gastric banding is gastric erosion. We review here our experience over a 5-year period. METHODS A total of 1496 patients underwent gastric banding. Eighty-five percent of patients were

Stomaplasty with pannicuectomy in an obese patient with stomal retraction: A case report.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Stomal retraction is a common complication following stoma formation. A repeat surgical procedure for stomal revision is an invasive treatment that is often required as a result. METHODS An 81-year-old woman with obstructive rectal carcinoma and perforative peritonitis underwent an
BACKGROUND Morbidly obese patients are at high risk for perioperative complications, including surgical site infections. Baseline arterial oxygenation is low in the morbidly obese, leading to low tissue oxygenation, which in turn is a primary determinant of infection risk. We therefore tested the
A recent gastric bypass can mask the symptoms of an acute abdomen. Physical examination is generally unreliable and subtle clinical symptoms or signs should alert clinicians to a significant postoperative problem. In morbidly obese patients, the presence of overt peritoneal findings is usually
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge